-Synuclein in Parkinson's DiseaseLeonidas Stefanis|Cold Spring Harbor Perspectives in Medicine|2011Cited by 1.4k
Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal CellsTereza Vogiatzi, Leonidas Stefanis|Journal of Biological Chemistry|2008Cited by 664
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyOwen A. Ross, Hiroyuki Tomiyama, Alexandra I. Soto‐Ortolaza et al.|The Lancet Neurology|2011Cited by 344
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated GliaOliver H. Tam, Molly Hammell, Robert W. Baloh et al.|Cell Reports|2019Cited by 333
Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s diseaseGeorgia Kouroupi, Rebecca Matsas, Era Taoufik et al.|Proceedings of the National Academy of Sciences|2017Cited by 156